Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
1
users have commented on this narrative
17
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
11
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Happiest Minds Technologies
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Global Automation And Rising Integration Costs Will Erode IT Margins
Key Takeaways Heavy reliance on traditional IT services and key clients exposes the company to automation risks and revenue volatility amid growing low-cost competition. Rising costs from talent retention, technology investments, and regulatory compliance threaten sustained margin pressure and slower growth in core markets.
View narrative
₹454.33
FV
29.7% overvalued
intrinsic discount
8.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
HMS Networks
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Tariff And Geopolitical Risks Will Strain Manufacturing Yet Improve Conditions
Key Takeaways Geopolitical tensions, tariffs, and currency shifts create uncertainty, pressuring margins and limiting international and organic revenue growth despite Industry 4.0 tailwinds. Growth in software, services, and acquisitions is slowed by project delays and market caution, while increased competition threatens pricing power and sustainable earnings.
View narrative
SEK 440.00
FV
1.4% overvalued
intrinsic discount
14.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Sleep Cycle
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Embedded Trackers And Regulation Will Erode Sleep App Margins
Key Takeaways Deep integration of free health tracking by major platforms and bundled offerings threatens user growth, retention, and the relevance of standalone sleep apps. Rising compliance costs and the shift toward medical-grade solutions will squeeze margins and challenge Sleep Cycle's long-term profitability.
View narrative
SEK 26.00
FV
11.5% overvalued
intrinsic discount
14.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Noah Holdings
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
China's Tightening Rules And Aging Population Will Sap Confidence
Key Takeaways Regulatory pressures, demographic challenges, and geopolitical risks threaten the company's international expansion, revenue growth, and long-term client retention. Increased competition, reputational concerns, and the shift to direct investment platforms are likely to erode market share and suppress profitability.
View narrative
US$6.80
FV
77.7% overvalued
intrinsic discount
0.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Forterra
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Rising Regulations And Shifting Construction Trends Will Weigh On Performance
Key Takeaways Rising regulatory and environmental pressures, combined with input cost inflation, threaten profitability through higher compliance costs and margin compression. Shifting market preferences toward alternative construction methods and demographic stagnation pose long-term risks to revenue growth and demand for core products.
View narrative
UK£1.70
FV
13.4% overvalued
intrinsic discount
2.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Cosmo Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
EMA Hurdles And Generics Will Stall Growth But Enable Recovery
Key Takeaways Heavy reliance on a few key drugs and regulatory uncertainties create risks for long-term growth and profitability despite strong demand and innovation efforts. Mounting pricing pressures, competition from generics, and slow regulatory approval could erode margins and limit international expansion opportunities.
View narrative
CHF 79.38
FV
27.7% undervalued
intrinsic discount
1.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Costain Group
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Rising UK Regulatory Costs And Fixed Contracts Will Pressure Margins
Key Takeaways Rising decarbonization regulation, labor costs, and fixed-price contracts threaten Costain's operating margins, exposing it to cost inflation and delivery risks. Shifting market dynamics and client preferences may limit Costain's growth opportunities, endangering revenue streams and competitiveness in securing major contracts.
View narrative
UK£1.15
FV
42.1% overvalued
intrinsic discount
3.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Life Healthcare Group Holdings
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Rising Regulatory Burdens And Costs Will Shrink South African Demand
Key Takeaways Long-term revenue growth is threatened by shifts to outpatient care, rising labor costs, and regulatory pressures constraining pricing power and margins. Structural economic and affordability barriers, along with high fixed costs, may limit patient volumes and dampen returns on investment.
View narrative
R12.30
FV
13.3% overvalued
intrinsic discount
2.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
PVA TePla
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Geopolitical Tensions And Stricter Regulations Will Limit Semiconductor Expansion
Key Takeaways Geopolitical fragmentation, protectionism, and environmental regulations pose significant risks to growth, market access, and profitability through increased operational costs and compliance burdens. Reliance on limited technologies and aggressive expansion without secure demand may cause revenue instability, margin compression, and vulnerability to shifting industry trends.
View narrative
€15.50
FV
54.8% overvalued
intrinsic discount
8.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies